About
About Rion Co., Ltd
Rion Co., Ltd. develops, manufactures, sells, and services particle counters, medical equipment, and environmental equipment in Japan. The company's audiological equipment includes hearing instruments, such as maxience, premience, wireless, Precia II / Precia IIV, classe series, high power series II, and trimmer type digital hearing aid; analog and digital BTE, trimmer digital BTE, in-the-ear ready and custom-made, and analog body aid instruments; and medical equipment comprising audiometers, impedance audiometer, and eustachian tube function meter. Its sound and vibration measuring instruments include sound level meters, vibration meters, seismometers, frequency analyzers, microphones and accelerometers, and other products. The company's particle counters comprise air and liquid-borne particle counters, and viable particle counters. Its products are primarily used in the applications of environment-related administration, electronics, semiconductors, pharmaceutical, and food manufacturing industries. The company was formerly known as Kobayashi-Riken Seisakusho Ltd. and changed its name to Rion Co., Ltd. in 1960. Rion Co., Ltd. was incorporated in 1944 and is headquartered in Kokubunji, Japan.
Research context
Rion Co., Ltd appears in PyInvesting’s Tokyo Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- JPY
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Visit company website
5 years, 7 months ago
Rion Co., Ltd is currently in a long term downtrend where the price is trading 5.0% below its 200 day moving average.
From a valuation standpoint, the stock is 97.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.7.
Rion Co., Ltd's total revenue rose by 7.8% to $5B since the same quarter in the previous year.
Its net income has increased by 45.1% to $459M since the same quarter in the previous year.
Based on the above factors, Rion Co., Ltd gets an overall score of 3/5.